These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 2580145

  • 1. Prenalterol as a selective cardiostimulant: differences between organ and receptor selectivity.
    Kenakin TP.
    J Cardiovasc Pharmacol; 1985; 7(1):208-10. PubMed ID: 2580145
    [No Abstract] [Full Text] [Related]

  • 2. In vitro studies on the cardiac activity of prenalterol with reference to use in congestive heart failure.
    Kenakin TP, Beek D.
    J Pharmacol Exp Ther; 1982 Jan; 220(1):77-85. PubMed ID: 6118432
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Influence of long-term beta receptor stimulation with prenalterol on intrinsic heart rate in rats.
    Nylander E, Dahlström U.
    Eur J Appl Physiol Occup Physiol; 1984 Jan; 53(1):48-52. PubMed ID: 6150847
    [Abstract] [Full Text] [Related]

  • 6. Is prenalterol (H133/80) really a selective beta 1 adrenoceptor agonist? Tissue selectivity resulting from differences in stimulus-response relationships.
    Kenakin TP, Beek D.
    J Pharmacol Exp Ther; 1980 May; 213(2):406-13. PubMed ID: 6102602
    [No Abstract] [Full Text] [Related]

  • 7. Cardio-selective beta adrenergic stimulation with prenalterol in the conscious dog.
    Manders WT, Vatner SF, Braunwald E.
    J Pharmacol Exp Ther; 1980 Oct; 215(1):266-70. PubMed ID: 6109017
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intrinsic sympathomimetic activity of the partial agonist prenalterol in relation to beta adrenoceptor interaction in various tissues, in vitro.
    Mattsson H, Hedberg A, Carlsson E.
    J Pharmacol Exp Ther; 1983 Mar; 224(3):654-61. PubMed ID: 6131123
    [Abstract] [Full Text] [Related]

  • 10. Role of cyclic AMP in cardiac beta-adrenoceptor desensitization: studies using prenalterol and inhibitors of phosphodiesterase.
    Bobik A, Little PJ.
    J Cardiovasc Pharmacol; 1984 Mar; 6(5):795-801. PubMed ID: 6209482
    [Abstract] [Full Text] [Related]

  • 11. Effects of in vivo beta-adrenoceptor down-regulation on cardiac responses to prenalterol and pirbuterol.
    Kenakin TP, Ferris RM.
    J Cardiovasc Pharmacol; 1983 Mar; 5(1):90-7. PubMed ID: 6186866
    [Abstract] [Full Text] [Related]

  • 12. Beta-1-adrenoceptor agonists with low adenylate cyclase activation--theoretical and clinical implications.
    Chemnitius JM, Bing RJ.
    Can J Cardiol; 1985 Mar; 1(3):186-90. PubMed ID: 2864992
    [Abstract] [Full Text] [Related]

  • 13. [Prenalterol (Hyprenan). A new cardiotonic agent].
    Pelle H, Svendsen TL, Kampmann JP.
    Ugeskr Laeger; 1982 Dec 06; 144(49):3688-90. PubMed ID: 6133384
    [No Abstract] [Full Text] [Related]

  • 14. Basic pharmacological properties of prenalterol.
    Mattsson H, Hedberg A, Carlsson E.
    Acta Med Scand Suppl; 1982 Dec 06; 659():9-37. PubMed ID: 6127902
    [No Abstract] [Full Text] [Related]

  • 15. Effects of selective and nonselective beta-agonists on plasma potassium and norepinephrine.
    Vincent HH, Boomsma F, Man in't Veld AJ, Derkx FH, Wenting GJ, Schalekamp MA.
    J Cardiovasc Pharmacol; 1984 Dec 06; 6(1):107-14. PubMed ID: 6199591
    [Abstract] [Full Text] [Related]

  • 16. Clinical experience of a new inotropic agent--Prenalterol--in hypotension and heart failure.
    Reiz S, Waagstein F, Hjalmarson A.
    Clin Cardiol; 1980 Apr 06; 3(2):96-105. PubMed ID: 6104553
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacological and clinical effects of prenalterol--a new inotropic beta-adrenoceptor stimulant. Proceedings of a symposium in Hamburg, December 5, 1980.
    Acta Med Scand Suppl; 1982 Apr 06; 659():1-325. PubMed ID: 6127881
    [No Abstract] [Full Text] [Related]

  • 18. Cardiovascular effects of prenalterol on rest and exercise haemodynamics in patients with chronic congestive cardiac failure.
    Tweddel AC, Murray RG, Pearson D, Martin W, Hutton I.
    Br Heart J; 1982 Apr 06; 47(4):375-80. PubMed ID: 6121566
    [Abstract] [Full Text] [Related]

  • 19. beta 1-and beta 2-adrenoceptor stimulatory effects of prenalterol.
    Mattsson H, Andersson T, Carlsson E, Hedberg A, Lundgren B, Olsson T.
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec 06; 321(4):302-8. PubMed ID: 6132344
    [Abstract] [Full Text] [Related]

  • 20. [Hemodynamic effects of a new beta-1 stimulating drug (prenalterol) in acute myocardial infarct in the open-chest pig].
    Branzi A, Binetti G, Specchia S, Magelli C, Zannoli R, Magnani B.
    Cardiologia; 1982 Dec 06; 27(1):33-43. PubMed ID: 6152732
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.